Abstract
Dendritic cells (DCs) are primary antigen-presenting cells involved in interactions with T cells leading to the proliferation of TH1 or TH2 cell types. In asthma, predominance of TH2 cells appears to be responsible for disease pathogenesis. Differentiation of T H2 cells is driven by a variety of factors such as the expression of high levels of costimulatory molecules, the cytokine profile, and the subset of DCs. Many inflammatory cells involved in the pathogenesis of asthma either directly or indirectly modulate DC function. Traditional treatments for asthma decrease the number of airway DCs in animals as well as in patients with asthma. Immunomodulators including interleukin (IL)-10, transforming growth factor (TGF)-β, cytosine-phosphate-guanosine-containing oligodeoxynucleotides (CpG-ODN), 1α,25-dihydroxyvitamin D3, and fetal liver tyrosine kinase 3 ligand (Flt3L) are involved in the modulation of the function of DCs. Based on the critical review of the interaction between DCs and other inflammatory cells, we propose that activation of T cells by DCs and sensitization to inhaled allergen and resulting airway inflammation are dependent on plasmacytoid and myeloid subset of lung DCs to induce an immune response or tolerance and are tightly regulated by T-regulatory cells. Effects of various therapeutic agents to modulate the function of lung myeloid DCs have been discussed.
| Original language | English |
|---|---|
| Pages (from-to) | 686-699 |
| Number of pages | 14 |
| Journal | Canadian Journal of Physiology and Pharmacology |
| Volume | 85 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 2007 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Physiology
- Pharmacology
Cite this
Dendritic cells in allergic airway inflammation. / Bharadwaj, Arpita S.; Bewtra, Againdra K.; Agrawal, Devendra K.
In: Canadian Journal of Physiology and Pharmacology, Vol. 85, No. 7, 07.2007, p. 686-699.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Dendritic cells in allergic airway inflammation
AU - Bharadwaj, Arpita S.
AU - Bewtra, Againdra K.
AU - Agrawal, Devendra K.
PY - 2007/7
Y1 - 2007/7
N2 - Dendritic cells (DCs) are primary antigen-presenting cells involved in interactions with T cells leading to the proliferation of TH1 or TH2 cell types. In asthma, predominance of TH2 cells appears to be responsible for disease pathogenesis. Differentiation of T H2 cells is driven by a variety of factors such as the expression of high levels of costimulatory molecules, the cytokine profile, and the subset of DCs. Many inflammatory cells involved in the pathogenesis of asthma either directly or indirectly modulate DC function. Traditional treatments for asthma decrease the number of airway DCs in animals as well as in patients with asthma. Immunomodulators including interleukin (IL)-10, transforming growth factor (TGF)-β, cytosine-phosphate-guanosine-containing oligodeoxynucleotides (CpG-ODN), 1α,25-dihydroxyvitamin D3, and fetal liver tyrosine kinase 3 ligand (Flt3L) are involved in the modulation of the function of DCs. Based on the critical review of the interaction between DCs and other inflammatory cells, we propose that activation of T cells by DCs and sensitization to inhaled allergen and resulting airway inflammation are dependent on plasmacytoid and myeloid subset of lung DCs to induce an immune response or tolerance and are tightly regulated by T-regulatory cells. Effects of various therapeutic agents to modulate the function of lung myeloid DCs have been discussed.
AB - Dendritic cells (DCs) are primary antigen-presenting cells involved in interactions with T cells leading to the proliferation of TH1 or TH2 cell types. In asthma, predominance of TH2 cells appears to be responsible for disease pathogenesis. Differentiation of T H2 cells is driven by a variety of factors such as the expression of high levels of costimulatory molecules, the cytokine profile, and the subset of DCs. Many inflammatory cells involved in the pathogenesis of asthma either directly or indirectly modulate DC function. Traditional treatments for asthma decrease the number of airway DCs in animals as well as in patients with asthma. Immunomodulators including interleukin (IL)-10, transforming growth factor (TGF)-β, cytosine-phosphate-guanosine-containing oligodeoxynucleotides (CpG-ODN), 1α,25-dihydroxyvitamin D3, and fetal liver tyrosine kinase 3 ligand (Flt3L) are involved in the modulation of the function of DCs. Based on the critical review of the interaction between DCs and other inflammatory cells, we propose that activation of T cells by DCs and sensitization to inhaled allergen and resulting airway inflammation are dependent on plasmacytoid and myeloid subset of lung DCs to induce an immune response or tolerance and are tightly regulated by T-regulatory cells. Effects of various therapeutic agents to modulate the function of lung myeloid DCs have been discussed.
UR - http://www.scopus.com/inward/record.url?scp=35649027982&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=35649027982&partnerID=8YFLogxK
U2 - 10.1139/Y07-062
DO - 10.1139/Y07-062
M3 - Article
C2 - 17823633
AN - SCOPUS:35649027982
VL - 85
SP - 686
EP - 699
JO - Canadian Journal of Physiology and Pharmacology
JF - Canadian Journal of Physiology and Pharmacology
SN - 0008-4212
IS - 7
ER -